Real World Data for Patients with Lung Cancer
APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
Recruiting
Observational Study
NSCLC
Cancer
Lung Cancer
Adenocarcinoma of Lung
Squamous Cell Lung Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,200 (estimated)
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Other
Who this trial is looking for
This trial is looking for patients with lung cancer to help build a network for sharing real-world data. Participants may receive innovative treatments and contribute to valuable research.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old.
- I have signed the informed consent form.
- I have been diagnosed with lung cancer.
- I have received or am eligible for innovative therapies.
You may not be able to join if
- I am taking unapproved cancer treatments.
- I have not received any innovative therapies.
- I have only had local treatments like surgery or radiation.
- I have only received standard chemotherapy.
- I had cancer therapies before 2010.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
APOLLO 11 main aim is to build a strong Italian long-lasting lung cancer network (in around 48 Italian centres) on real world data and translational research by creating a decentralized long-term national database (settle locally in each centre) and a "virtual" multilevel biobank in each centre. Besides, APOLLO 11 will take advantage of the translational research joint effort with the credo "unity…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Provision of signed and dated written informed consent, when applicable, by the patient or legally acceptable representative prior to any mandatory study-specific procedures, sampling, and analyses;
2. Patients must be ≥18 years of age at the time of signing the informed cons…
Contacts